• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 PoissonERM 进行二项结局的自动化泊松回归暴露-反应分析。

Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERM.

机构信息

Pfizer Inc, South San Francisco, California, USA.

Pfizer Inc, Cambridge, Massachusetts, USA.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1615-1629. doi: 10.1002/psp4.13207. Epub 2024 Jul 31.

DOI:10.1002/psp4.13207
PMID:39086047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11494912/
Abstract

PoissonERM is an R package used to conduct exposure-response (ER) analysis on binary outcomes for establishing the relationship between exposure and the occurrence of adverse events (AE). While Poisson regression could be implemented with glm(), PoissonERM provides a simple way to semi-automate the entire analysis and generate an abbreviated report as an R markdown (Rmd) file that includes the essential analysis details with brief conclusions. PoissonERM processes the provided data set using the information from the user's control script and generates summary tables/figures for the exposure metrics, covariates, and event counts of each endpoint (each type of AE). After checking the incidence rate of each AE, the correlation, and missing values in each covariate, an exposure-response model is developed for each endpoint based on the provided specifications. PoissonERM has the flexibility to incorporate and compare multiple scale transformations in its modeling. The best exposure metric is selected based on a univariate model's p-value or deviance ( ) as specified. If a covariate search is specified in the control script, the final model is developed using backward elimination. PoissonERM identifies and avoids highly correlated covariates in the final model development of each endpoint. Predicting event incidence rates using external (simulated) exposure metric data is an additional functionality in PoissonERM, which is useful to understand the event occurrence associated with certain dose regimens. The summary outputs of the cleaned data, model developments, and predictions are saved in the working folder and can be compiled into a HTML report using Rmd.

摘要

PoissonERM 是一个用于分析二元结局的暴露-反应(ER)的 R 包,旨在建立暴露与不良事件(AE)发生之间的关系。虽然可以使用 glm() 进行泊松回归,但 PoissonERM 提供了一种简单的方法,可以半自动完成整个分析,并生成一个缩写的报告作为 R 标记(Rmd)文件,其中包含带有简短结论的基本分析细节。PoissonERM 使用用户控制脚本中的信息处理提供的数据集,并为每个终点(每种 AE)生成暴露指标、协变量和事件计数的汇总表/图。在检查每个 AE 的发病率、相关性和每个协变量中的缺失值后,根据提供的规范为每个终点开发暴露反应模型。PoissonERM 具有在其建模中纳入和比较多种比例变换的灵活性。根据指定的单变量模型 p 值或方差( )选择最佳暴露指标。如果在控制脚本中指定了协变量搜索,则使用后向消除法开发最终模型。PoissonERM 在每个终点的最终模型开发中识别和避免高度相关的协变量。使用外部(模拟)暴露指标数据预测事件发生率是 PoissonERM 的另一个功能,这对于理解与某些剂量方案相关的事件发生非常有用。清理后的数据、模型开发和预测的摘要输出保存在工作文件夹中,并可以使用 Rmd 编译成 HTML 报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/de8bb42841a8/PSP4-13-1615-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/c6dc9d8aeca5/PSP4-13-1615-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/389dffcc7dc7/PSP4-13-1615-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/de8bb42841a8/PSP4-13-1615-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/c6dc9d8aeca5/PSP4-13-1615-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/389dffcc7dc7/PSP4-13-1615-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/11494912/de8bb42841a8/PSP4-13-1615-g002.jpg

相似文献

1
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERM.使用 PoissonERM 进行二项结局的自动化泊松回归暴露-反应分析。
CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1615-1629. doi: 10.1002/psp4.13207. Epub 2024 Jul 31.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM, BC, NO, and O: An Analysis of European Cohorts in the ELAPSE Project.长期暴露于低水平 PM、BC、NO 和 O 对死亡率和发病率的影响:ELAPSE 项目中欧洲队列的分析。
Res Rep Health Eff Inst. 2021 Sep;2021(208):1-127.
4
Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.1990年香港燃料含硫量限制立法的影响。
Res Rep Health Eff Inst. 2012 Aug(170):5-91.
5
NHPPREG: a computer program for the analysis of nonhomogeneous Poisson process data with covariates.NHPPREG:一个用于分析带有协变量的非齐次泊松过程数据的计算机程序。
Comput Methods Programs Biomed. 1992 Jun;38(1):37-48. doi: 10.1016/0169-2607(92)90073-g.
6
Enhancing Models and Measurements of Traffic-Related Air Pollutants for Health Studies Using Dispersion Modeling and Bayesian Data Fusion.利用扩散模型和贝叶斯数据融合技术改进交通相关空气污染物的模型和测量方法,以用于健康研究。
Res Rep Health Eff Inst. 2020 Mar;2020(202):1-63.
7
Odds ratios from logistic, geometric, Poisson, and negative binomial regression models.逻辑斯蒂回归、几何平均回归、泊松回归和负二项回归模型的优势比。
BMC Med Res Methodol. 2018 Oct 20;18(1):112. doi: 10.1186/s12874-018-0568-9.
8
Statistical issues in the analysis of adverse events in time-to-event data.事件发生时间数据中不良事件分析的统计学问题。
Pharm Stat. 2016 Jul;15(4):297-305. doi: 10.1002/pst.1739. Epub 2016 Mar 1.
9
Poisson regression analysis of ungrouped data.未分组数据的泊松回归分析。
Occup Environ Med. 2005 May;62(5):325-9. doi: 10.1136/oem.2004.017459.
10
Personal exposure to mixtures of volatile organic compounds: modeling and further analysis of the RIOPA data.个人对挥发性有机化合物混合物的暴露:RIOPA数据的建模与进一步分析
Res Rep Health Eff Inst. 2014 Jun(181):3-63.

本文引用的文献

1
Confounded exposure metrics.混杂的暴露指标。
CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):187-191. doi: 10.1002/psp4.13074. Epub 2023 Nov 20.
2
Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII.依库珠单抗用于预防伴/不伴因子 VIII 抑制物的血友病 A 患者出血的暴露-出血计数模型建立
Clin Pharmacokinet. 2021 Jul;60(7):931-941. doi: 10.1007/s40262-021-01006-0. Epub 2021 Mar 12.
3
Population pharmacokinetics-pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex.
口服依维莫司治疗与结节性硬化症相关癫痫患者的群体药代动力学-药效学研究。
J Pharmacokinet Pharmacodyn. 2018 Oct;45(5):707-719. doi: 10.1007/s10928-018-9600-2. Epub 2018 Jul 10.
4
Statistical Methods for Recurrent Event Analysis in Cohort Studies of CKD.在慢性肾脏病队列研究中,复发性事件分析的统计方法。
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2066-2073. doi: 10.2215/CJN.12841216. Epub 2017 Jul 17.
5
Exposure-disease response analysis of natalizumab in subjects with multiple sclerosis.那他珠单抗在多发性硬化症患者中的暴露-疾病反应分析。
J Pharmacokinet Pharmacodyn. 2017 Jun;44(3):263-275. doi: 10.1007/s10928-017-9514-4. Epub 2017 Mar 1.
6
Modeling and simulation of count data.计数数据的建模与模拟。
CPT Pharmacometrics Syst Pharmacol. 2014 Aug 13;3(8):e129. doi: 10.1038/psp.2014.27.
7
Comparison of methods for handling missing covariate data.缺失协变量数据处理方法的比较。
AAPS J. 2013 Oct;15(4):1232-41. doi: 10.1208/s12248-013-9526-y.
8
Comparison of statistical approaches to evaluate factors associated with metabolic syndrome.比较评估与代谢综合征相关因素的统计学方法。
J Clin Hypertens (Greenwich). 2010 May;12(5):365-73. doi: 10.1111/j.1751-7176.2010.00264.x.
9
Estimating the relative risk in cohort studies and clinical trials of common outcomes.在队列研究和常见结局的临床试验中估计相对风险。
Am J Epidemiol. 2003 May 15;157(10):940-3. doi: 10.1093/aje/kwg074.
10
Markov models in medical decision making: a practical guide.医学决策中的马尔可夫模型:实用指南。
Med Decis Making. 1993 Oct-Dec;13(4):322-38. doi: 10.1177/0272989X9301300409.